Choking Emergency Preparedness Blog

A 2026 regulatory explainer showing why 'FDA registered' is not the same as FDA-authorized, what QXN and 21 CFR 874.5400 mean, and why authorized status reflects both legal identity and performance expectations after unsuccessful BLS.

An evidence-led Fitiger article explaining who is inside the FDA-authorized intended-use population for anti-choking devices, what the known risks are, and why safety depends on preserving first-line rescue before second-line suction use.

A Fitiger engineering and product safety team review of what the best current evidence actually shows about anti-choking devices. The article explains the difference between mechanical plausibility and clinical superiority, why FDA treats suction as second-line after unsuccessful BLS, and how simulation, case-series, cadaver, bench, and systematic-review evidence should be read in 2026.